214 related articles for article (PubMed ID: 31988356)
1. Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients.
Tang T; Zhuo Y; Xie L; Wang H; Yang M
Sci Rep; 2020 Jan; 10(1):1260. PubMed ID: 31988356
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients.
Ren C; Su H; Tao J; Xie Y; Zhang X; Guo Q
Clin Interv Aging; 2022; 17():211-221. PubMed ID: 35256845
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: A retrospective cohort study from the China Health and Retirement Longitudinal Study.
Wu Y; Wang H; Tong Y; Zhang X; Long Y; Li Q; Ren J; Liu C
Front Public Health; 2023; 11():1122922. PubMed ID: 37026117
[TBL] [Abstract][Full Text] [Related]
4. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.
Tang T; Xie L; Hu S; Tan L; Lei X; Luo X; Yang L; Yang M
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1800-1810. PubMed ID: 35297568
[TBL] [Abstract][Full Text] [Related]
5. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
Amado CA; García-Unzueta MT; Lavin BA; Guerra AR; Agüero J; Ramos L; Muñoz P
Respiration; 2019; 97(4):302-309. PubMed ID: 30481791
[TBL] [Abstract][Full Text] [Related]
6. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
[TBL] [Abstract][Full Text] [Related]
7. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.
Barreto EF; Poyant JO; Coville HH; Dierkhising RA; Kennedy CC; Gajic O; Nystrom EM; Takahashi N; Moynagh MR; Kashani KB
Clin Nutr; 2019 Jun; 38(3):1362-1367. PubMed ID: 29921462
[TBL] [Abstract][Full Text] [Related]
8. Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia.
Kusunoki H; Tsuji S; Kusukawa T; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Shinmura K
Clin Exp Nephrol; 2021 Mar; 25(3):231-239. PubMed ID: 33090338
[TBL] [Abstract][Full Text] [Related]
9. A baseline sarcopenia index based on creatinine/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes.
Hou L; Chen X; Zhu C
Front Public Health; 2023; 11():1049738. PubMed ID: 37841730
[TBL] [Abstract][Full Text] [Related]
10. The Role of Baseline Sarcopenia Index in Predicting Chemotherapy-Induced Undesirable Effects and Mortality in Older People with Stage III or IV Non-Small Cell Lung Cancer.
Chen X; Hou L; Shen Y; Wu X; Dong B; Hao Q
J Nutr Health Aging; 2021; 25(7):878-882. PubMed ID: 34409965
[TBL] [Abstract][Full Text] [Related]
11. A sarcopenia screening test predicts mortality in hospitalized older adults.
Tang T; Wu L; Yang L; Jiang J; Hao Q; Dong B; Yang M
Sci Rep; 2018 Feb; 8(1):2923. PubMed ID: 29440681
[TBL] [Abstract][Full Text] [Related]
12. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
13. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study.
Tabara Y; Kohara K; Okada Y; Ohyagi Y; Igase M
Clin Nutr; 2020 Jun; 39(6):1857-1862. PubMed ID: 31431305
[TBL] [Abstract][Full Text] [Related]
14. Low glomerular filtration rate as an associated risk factor for sarcopenic muscle strength: is creatinine or cystatin C-based estimation more relevant?
Tufan A; Tufan F; Akpinar TS; Ilhan B; Bahat G; Karan MA
Aging Male; 2017 Jun; 20(2):110-114. PubMed ID: 27650550
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the serum creatinine/cystatin C ratio as a blood biomarker for sarcopenia components among age groups in community-dwelling older people: The SONIC study.
Fang W; Godai K; Kabayama M; Akagi Y; Kido M; Akasaka H; Takami Y; Ikebe K; Arai Y; Masui Y; Ishizaki T; Yasumoto S; Gondo Y; Yamamoto K; Tabara Y; Kamide K
Geriatr Gerontol Int; 2024 Jun; 24(6):529-536. PubMed ID: 38622852
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of the sarcopenia index in predicting septic shock and death in elderly patients with community-acquired pneumonia.
Huang S; Zhao L; Liu Z; Li Y; Wang X; Li J; Chen X
BMC Geriatr; 2022 Apr; 22(1):341. PubMed ID: 35439963
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study.
Yang M; Hu X; Wang H; Zhang L; Hao Q; Dong B
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):251-258. PubMed ID: 27896949
[TBL] [Abstract][Full Text] [Related]
18. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.
Kashani K; Sarvottam K; Pereira NL; Barreto EF; Kennedy CC
Clin Transplant; 2018 Mar; 32(3):e13182. PubMed ID: 29274246
[TBL] [Abstract][Full Text] [Related]
19. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
Zhao X; Su R; Hu R; Chen Y; Xu X; Yuan Y; Zhang J; Zhang W; Yang Y; Chen M; Li D; Wu B; Huang D; Wu D
BMC Geriatr; 2023 Feb; 23(1):89. PubMed ID: 36774462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
